RDF/XML JSON-LD N3/Turtle RDF/JSON
Perfil en el portal institucional

Quintela Fandiño, Miguel Angel miguel.quintela@uam.es

Medicina / Universidad Autónoma de Madrid

Actividades

DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy

  • Quintela-Fandino, Miguel
  • Hitt, Ricardo
  • Medina, Pedro P.
  • Gamarra, Soledad
  • Manso, Luis
  • Cortes-Funes, Hernan
  • Sanchez-Cespedes, Montserrat;
... Ver más Contraer

Journal Of Clinical Oncology (p. 4333-4339) - 10/9/2006

10.1200/jco.2006.05.8768 Ver en origen

  • ISSN 0732183X

Prediction of Response to Targeted Therapies in Lung Cancer Using Dynamic Imaging: Still Far From Clinical Implementation

  • Quintela-Fandino, Miguel
  • Colomer, Ramon;

Journal Of Clinical Oncology (p. 3716-3718) - 20/9/2011

10.1200/jco.2011.37.1427 Ver en origen

  • ISSN 0732183X

Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support

  • Quintela-Fandino, Miguel
  • Lopez, Joaquin Martinez
  • Hitt, Ricardo
  • Gamarra, Soledad
  • Jimeno, Antonio
  • Ayala, Rosa
  • Hornedo, Javier
  • Guzman, Cecilia
  • Gilsanz, Florinda
  • Cortes-Funes, Hernan
... Ver más Contraer

Journal Of Clinical Oncology (p. 3611-3618) - 1/8/2006

10.1200/jco.2005.04.0576 Ver en origen

  • ISSN 0732183X

Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets

  • Tusche, Michael W.
  • Ward, Lesley A.
  • Vu, Frances
  • McCarthy, Doug
  • Quintela-Fandino, Miguel
  • Ruland, Jurgen
  • Gommerman, Jennifer L.
  • Mak, Tak W.;
... Ver más Contraer

Journal Of Experimental Medicine (p. 2671-2683) - 23/11/2009

10.1084/jem.20091802 Ver en origen

  • ISSN 00221007

Emerging role of Fatty acid synthase in tumor initiation: implications for cancer prevention

  • Bueno MJ
  • Quintela-Fandino M

Mol Cell Oncol - 3/3/2020

10.1080/23723556.2019.1709389 Ver en origen

  • ISSN 23723556

Normoxic or hypoxic adaptation in response to antiangiogenic therapy: Clinical implications

  • Quintela-Fandino, M.;

Mol Cell Oncol - 2/9/2016

10.1080/23723556.2016.1217368 Ver en origen

  • ISSN 23723556

Phase I Combination of Sorafenib and Erlotinib Therapy in Solid Tumors: Safety, Pharmacokinetic, and Pharmacodynamic Evaluation from an Expansion Cohort

  • Quintela-Fandino, Miguel
  • Le Tourneau, Christophe
  • Duran, Ignacio
  • Chen, Eric X.
  • Wang, Lisa
  • Tsao, Ming
  • Bandarchi-Chamkhaleh, Bizhan
  • Pham, Nhu-Ann
  • Do, Trevor
  • MacLean, Martha
  • Nayyar, Rakesh
  • Tusche, Michael W.
  • Metser, Ur
  • Wright, John J.
  • Mak, Tak W.
  • Siu, Lillian L.;
... Ver más Contraer

Molecular Cancer Therapeutics (p. 751-760) - 1/3/2010

10.1158/1535-7163.mct-09-0868 Ver en origen

  • ISSN 15357163
Open Access

Monitoring vascular normalization induced by antiangiogenic treatment with F-18-fluoromisonidazole-PET

  • Hernández Agudo, Elena
  • Mondejar, Tamara
  • Soto Montenegro, Mª Luisa
  • Megías, Diego
  • Mourón, Silvana
  • Sánchez, Jesús
  • Hidalgo, Manuel
  • López Casas, Pedro Pablo
  • Mulero, Francisca
  • Desco Menendez, Manuel
  • Quintela Fandino, Miguel
... Ver más Contraer

Molecular Oncology (p. 704-718) - 1/5/2016

10.1016/j.molonc.2015.12.011 Ver en origen

  • ISSN 1878-0261

Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: Results of the CNIO-BR002 phase I-trial

  • Quintela-Fandino, Miguel
  • Bueno, Maria J.
  • Lombardia, Luis
  • Gil, Marta
  • Gonzalez-Martin, Antonio
  • Marquez, Raul
  • Bratos, Raquel
  • Guerra, Juan
  • Tan, Eugene
  • Lopez, Antonio
  • Colomer, Ramon
  • Salazar, Ramon;
... Ver más Contraer

Molecular Oncology (p. 1719-1728) - 1/12/2014

10.1016/j.molonc.2014.07.005

  • ISSN 15747891
  • iMarina

Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells

  • Hühn D
  • Martí-Rodrigo P
  • Mouron S
  • Hansel C
  • Tschapalda K
  • Porebski B
  • Häggblad M
  • Lidemalm L
  • Quintela-Fandino M
  • Carreras-Puigvert J
  • Fernandez-Capetillo O
... Ver más Contraer

Molecular Oncology (p. 148-165) - 1/1/2022

10.1002/1878-0261.13083 Ver en origen

  • ISSN 15747891

Este/a investigador/a no tiene libros.

Este/a investigador/a no tiene capítulos de libro.

Phase I clinical trial of neoadjuvant BIBF1120 plus weekly paclitaxel (P) in early HER-2 negative breast cancer. CNIO-BR-01-2010 GEICAM 2010-10 study

  • Quintela-Fandino, M.
  • Urruticoechea, A.
  • Guerra, J.
  • Gil, M.
  • Gonzalez-Martin, A.
  • Marquez, R.
  • Hernandez-Agudo, E.
  • Rodriguez-Martin, C.
  • Gil, M.
  • Bratos, R.
  • Escudero, M. J.
  • Colomer, R.;
... Ver más Contraer

Cancer Research - 15/12/2013

10.1158/0008-5472.sabcs13-pd5-8 Ver en origen

  • ISSN 00085472

Este/a investigador/a no tiene documentos de trabajo.

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3K?/?, in Patients with Advanced Solid Tumors

  • Choudhury AD, Higano CS, de Bono JS, Cook N, Rathkopf DE, Wisinski KB, Martin-Liberal J, Linch M, Heath EI, Baird RD, García-Carbacho J, Quintela-Fandino M, Barry ST, de Bruin EC, Colebrook S, Hawkins G, Klinowska T, Maroj B, Moorthy G, Mortimer PG, Moschetta M, Nikolaou M, Sainsbury L, Shapiro GI, Siu LL, Hansen AR

Clinical Cancer Research (p. 2257-2269) - 1/1/2022

10.1158/1078-0432.ccr-21-3087 Ver en origen

  • ISSN 15573265

Este/a investigador/a no tiene proyectos de investigación.

Triple negative breast cancer kinome-taxonomy, prognostic and therapeutics: role of polynucleotide kinase-phosphatase

  • QUINTELA FANDIÑO, MIGUEL ANGEL (Director) Doctorando: Fernández Gaitero, Sara

4/3/2021

  • iMarina

Este/a investigador/a no tiene patentes o licencias de software.

Última actualización de los datos: 18/03/24 14:43